RAKS-dev20/RAKS-dev20

This is a 16-day-old personal research repository with zero stars, forks, or activity velocity. The description reflects an MSc student's research interests rather than a shipped project. No users, no adoption, no code artifacts visible in the repository itself—only a profile/bio statement. The work is derivative of existing computational drug discovery and molecular docking methodologies (standard techniques in the field: RDKit, AutoDock, Glide-equivalents, ADMET predictors). While the specific focus on BRD4 and HDAC6 epigenetic regulators may be novel in its application, the underlying techniques are commodity. There is no defensible moat: molecular docking software is mature (Schrödinger, GROMACS, open-source alternatives), ADMET prediction is solved via established ML models, and structural biology tools are well-established. Frontier labs would not compete with this—it is a student research project, not a product. Low frontier risk because this does not threaten any platform capability; it is domain-specific academic research. No composability value: the repository appears to be a placeholder or CV statement rather than a reusable library or framework.